8th European GMP Conference Pre-Conference - GMP for Cannabis - what you need to know

5 June 2019, Heidelberg, Germany

Seminar-Nr. 17271


Medical cannabis has been permitted for prescription in Germany since 2017, causing a need for producers supplying pharmacists and physicians with the newly "legalized" drug. But what qualifies as medical grade cannabis? This conference will give you an overview of all relevant regulatory and GMP/GDP requirements and aspects of medical cannabis.


In March 2017, the national German legislature expanded the options for prescribing medical cannabis products by passing a law amending provisions under the Narcotics Law and other regulations. These products, however, must comply with the relevant requirements laid down under Medicinal and Narcotics Law, including GMP and GDP. Therefore, the BfArM (the Federal Institute for Drugs and Medical Devices) has taken over new responsibilities by establishing the Cannabis Agency. This agency is meant to help in ensuring supplies for medical-quality cannabis.

Unlike AGES in Austria, though, where cultivation of medical cannabis has already been established, cannabis will not be cultivated by BfArM itself, but by commissioned companies. Cannabis is not meant to be stored directly at BfArM during any stage of the purchasing, harvesting or distribution process. These steps will be carried out by relevant producers or other commissioned companies (i.e. suppliers, importers). Hence, the agency will manage and monitor the cultivation, harvest, processing, quality assurance, storage, packaging and distribution of cannabis to wholesalers, chemists or manufacturers.

The GMP inspectorates are responsible for issuing manufacturing and import licenses or GMP Certificates. Thus, they will perform inspections at the sites of manufacturers who apply for these certificates and licenses.
In summary:
The Cannabis Agency is responsible for ensuring that only medical grade cannabis is supplied,
The relevant requirements based on the underlying legal framework (including Pharmacopoeias) and the corresponding GMP, GDP and GACP guidelines must be complied with, and finally
Cannabis for medical purposes is also subject to the provisions of the German Narcotics Law.


This conference addresses specific GMP aspects to consider for Growers, Manufacturers, Start-Ups, Suppliers, Importers, QPs and QA personnel involved in Cannabis production. The topics provided are also of interest for GMP/GDP Inspectors responsible for issuing a GMP- certificate or manufacturers- / import license.


8th European GMP Conference Pre-Conference - GMP for Cannabis - what you need to know

Gesamtes Programm als PDF herunterladen

Welcome and Introduction
GMP for Cannabis: setting the scene

Production of Cannabis flos for medical purpose
Good Agricultural and Collection Practice, GACP
Cannabis Production / Infrastructure / Monitoring
Security Measures

GMP Certification / Manufacturing and Importation Authorization
Aspects to consider for applications for Manufacturing and Importation Authorizations
GMP certification: What you need to know
Inspections in Europe and beyond: Typical and recurrent compliance issues

Narcotic drugs - The regulations
Short overview of the German Narcotics Law ("Betäubungsmittelgesetz", BtMG)
Necessary documents for granting general licenses and import / export authorizations by the Federal Opium Agency (BfArM)
Reasons for refusal

GDP for Cannabis
Requirements for transport to pharmacies, veterinary dispensaries, hospitals
Requirements for distribution of cannabis through international distribution partners, wholesalers and 3PL partners

Launch of Cannabis products
Requirements to fulfil
Infrastructure, global marketing and distribution agreements
Medicinal cannabis products like oils and oil derivate products such as capsules, sublingual wafers and topical creams

Supplier qualification and handling after import

Experiences - Lessons learned
Application of GMP principles to Cannabis
Quality management System (QMS) including Qualification/Validation
DAB Monograph "Cannabis Flos": Points to consider

Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Liste aller Seminare.

Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie in der Liste aller Aufzeichnungen.

Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.

* auch unkompliziert per Kreditkarte bezahlbar
American Express Visa Mastercard

Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
Weitere Termine online
Weitere Termine online nicht verfügbar
Aufzeichnung nicht verfügbar

Haben Sie noch Fragen?

Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
Tel.: +49 6221 84 44 0
E-Mail: info@concept-heidelberg.de

Frau mit Headset


Teilnehmerstimmen - das sagen andere über unsere Seminare:

Guter, breit gefächerter Überblick mit interessanten Verknüpfungen zur Praxis,
welche die Theorie super veranschaulicht.”
Marina Kicoranovic, Labor Hartmann GmbH
GMP/Basis-Einstiegsschulung (B 14), September 2023

Die Referenten waren sehr gut! Sie haben sehr klar gesprochen, nur sehr wenige englische Begriffe
verwendet (super) und waren sehr praxisbezogen.”
Astrid Gießler, Regierungspräsidium Karlsruhe
Live Online Seminar - Basiskurs Computervalidierung & Datenintegrität im GxP Umfeld (B 3), Juni 2023

Sehr guter Bezug zur Schulung für einen GMP-Anfänger. Habe mich sehr gut abgeholt gefühlt.”
Dr. Harald Werner, Infraserv GmbH & Co. Höchst KG
GMP-Basisschulung (B 1), Juni 2023